Use of inhibitors of the sodium-hydrogen exchanger for the production of a medicament for decreasing undesired effects of substrates of the heart

US6462024B1 · kind B1 · utility

Assignee

• Aventis Pharma Deutschland GmbH · DE

Inventors

• Hans-Jochen Lang · Hofheim, DE
• Hartmut Rutten · Idstein, DE
• Holger Heitsch · Hofheim, DE
• Wolfgang Linz · Mainz, DE
• Bernward Scholkens · Kelkheim, DE

Key dates

• Filing date: Jul 11, 2000
• Grant date: Oct 8, 2002
• Expiry date: Sep 17, 2020

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P39/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Inhibitors of the sodium-hydrogen exchanger are used for the production of a medicament for decreasing the undesired effects in human and in veterinary medicine which originate from substances which cause damage to the heart when administered acutely or chronically.